The DOI matches its Crossref record.
Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus
Abstract
The mechanism of resistance to the streptogramin antibiotics quinupristin and dalfopristin was studied in a Staphylococcus aureus clinical isolate selected under quinupristin-dalfopristin therapy, in four derivatives of S. aureus RN4220 selected in vitro, and in a mutant selected in a model of rabbit aortic endocarditis. For all strains the MICs of erythromycin, quinupristin, and quinupristin-dalfopristin were higher than those for the parental strains but the MICs of dalfopristin and lincomycin were similar. Portions of genes for domains II and V of 23S rRNA and the genes for ribosomal proteins L4 and L22 were amplified and sequenced. All mutants contained insertions or deletions in a protruding β hairpin that is part of the conserved C terminus of the L22 protein and that interacts with 23S rRNA. Susceptible S. aureus RN4220 was transformed with plasmid DNA encoding the L22 alteration, resulting in transformants that were erythromycin and quinupristin resistant. Synergistic ribosomal binding of streptogramins A and B, studied by analyzing the fluorescence kinetics of pristinamycin I A-ribosome complexes, was abolished in the mutant strain, providing an explanation for quinupristin-dalfopristin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Resistance to MLS-B can also result from mutations in chromosomal genes encoding ribosomal proteins, such as a mutation in the rplV gene encoding the L22 protein in the 50S subunit of the ribosome, which determines resistance to erythromycin, telithromycin, quinupristin, and dalfopristin in S. aureus [133]”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [133]
In the citing paper
“Resistance to quinupristin-dalfopristin in S. aureus is most often due to the presence of two mechanisms: constitutive resistance to MLS-B and resistance to streptogramin A.”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- 10.1128/AAC.40.11.2523 · DOI
- 10.1128/AAC.39.9.2027 · DOI
- 10.1016/S0378-1119(97)00464-2 · DOI
- 10.1128/AAC.42.7.1794 · DOI
- 10.1016/0378-1119(92)90488-B · DOI
- 10.1016/0147-619X(88)90034-0 · DOI
- 10.1016/0378-1119(93)90350-C · DOI
- Apirion, D. 1967. Three genes that affect Escherichia coli ribosomes. J. Mol. Biol.30:255-275.
- Aumercier, M., S. Bouhallab, M. L. Capmau, and F. Le Goffic. 1992. RP 59500: a proposed mechanism for its bactericidal activity. J. Antimicrob. Chemother.30(Suppl. A):9-14. · DOI
- 10.1126/science.289.5481.905 · DOI · Paper page
- 10.1517/13543784.7.4.591 · DOI
- Beyer, D., P. Vannuffel, and K. Pepper. 1998. Quinupristin (RP 57669): a new tool to investigate ribosome-group B streptogramin interactions. Biol. Chem.379:841-846. · doi:10.1515/bchm.1998.379.7.841
- 10.1128/AAC.43.11.2720 · DOI
- 10.1128/AAC.46.1.125-131.2002 · DOI · Paper page
- 10.1128/jb.176.20.6192-6198.1994 · DOI
- Cocito, C., and G. Chinali. 1985. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems. J. Antimicrob. Chemother.16(Suppl. A):35-52. · DOI
- Cocito, C., and M. Di Giambattista. 1978. The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. Mol. Gen. Genet.166:53-59. · doi:10.1007/bf00379729
- Comité de l'Antibiogramme de la Société Française de Microbiologie. 1996. 1996 report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Technical recommendations for in vitro susceptibility testing. Clin. Microbiol. Infect.2(Suppl. 1):11-25. · doi:10.1111/j.1469-0691.1996.tb00871.x
- Contreras, A., and D. Vazquez. 1977. Synergistic interaction of the streptogramins with the ribosome. Eur. J. Biochem.74:549-551. · doi:10.1111/j.1432-1033.1977.tb11423.x
- 10.1128/AAC.45.1.319-323.2001 · DOI
- 10.1016/S0021-9258(18)47454-6 · DOI
- Di Giambattista, M., E. Nyssen, A. Pecher, and C. Cocito. 1990. Affinity labeling of the virginiamycin S binding site on bacterial ribosome. Biochemistry29:9203-9211. · doi:10.1021/bi00491a014
- 10.1016/S0732-8893(99)00154-6 · DOI
- El Solh, N., and J. Allignet. 1998. Staphylococcal resistance to streptogramins and related antibiotics. Drug Res. Updates1:169-175. · doi:10.1016/s1368-7646(98)80036-8
- 10.1016/S1097-2765(01)00293-3 · DOI · Paper page
- 10.1006/jmbi.1999.2839 · DOI
- 10.1002/elps.1150181505 · DOI · Paper page
- 10.1093/clinids/10.4.867 · DOI · Paper page
- 10.1128/AAC.39.7.1505 · DOI
- 10.1038/305709a0 · DOI · Paper page
- Krogstad, D. J., and R. C. Moellering, Jr. 1986. Antimicrobial combinations, p. 537-595. In V. Lorian (ed.), Antibiotics in laboratory medicine, 2nd ed. Williams & Wilkins, Baltimore, Md.
- 10.1128/AAC.43.5.1062 · DOI · Paper page
- Low, D. E. 1995. Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience. Microb. Drug Resist.1:223-234. · DOI
- Mukhtar, T. A., K. P. Koteva, D. W. Hughes, and G. D. Wright. 2001. Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis. Biochemistry40:8877-8886. · DOI
- 10.1126/science.289.5481.920 · DOI · Paper page
- Nyssen, E., M. Di Giambattista, and C. Cocito. 1989. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. Biochim. Biophys. Acta1009:39-46. · DOI
- Parfait, R., M. Di Giambattista, and C. Cocito. 1981. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit. Biochim. Biophys. Acta654:236-241. · DOI
- 10.1042/bst0240274 · DOI · Paper page
- 10.1016/S0378-1119(96)00554-9 · DOI
- 10.1128/AAC.40.11.2562 · DOI · Paper page
- Unge, J., A. Aberg, S. Al-Kharadaghi, A. Nikulin, S. Nikonov, N. Davydova, N. Nevskaya, M. Garber, and A. Liljas. 1998. The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistance. Structure6:1577-1586. · DOI
- Vannuffel, P., M. Di Giambattista, and C. Cocito. 1992. The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J. Biol. Chem.267:16114-16120. · DOI
- 10.1128/AAC.45.1.1-12.2001 · DOI · Paper page
- 10.1128/AAC.44.5.1168-1173.2000 · DOI
Cited by
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus
Friedman, L., Alder, J. D., & Silverman, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-06 · Cited by 454
Tu, D., Blaha, G., Moore, P. B., & Steitz, T. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.005 · Cited by 433
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases · doi:10.1086/380125 · Cited by 156
Metadata
- Authors
- Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R.
- Affiliations
- Service de Microbiologie, CHU de Caen
- UFR Pharmacie, Caen
- INSERM EMI9933 and Bichat University, Paris
- Anti-Infective Clinical Research, Aventis, Vitry-sur-Seine, France
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-07
- Volume
- 46
- Issue
- 7
- Pages
- 2200-2207
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 70
- References
- 0
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus. https://app.cochat.ai/papers/10.1128/aac.46.7.2200-2207.2002
- The paper
- Malbruny, B., Canu, A., Bozdogan, B., Fantin, B., Zarrouk, V., Dutka-Malen, S., Feger, C., & Leclercq, R. (2002). Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.46.7.2200-2207.2002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.